FDA PMA FDA Class 3 Approved 🇺🇸 United States

Pump, Infusion, Implanted, Programmable

PMA: P080012 · Supplement: S068 · Decision Jan 12, 2022
Classifications
1
FEI Numbers
18
Registration Numbers
18

Basic Information

Device Name
Pump, Infusion, Implanted, Programmable
Trade Name
Prometra Programmable Infusion Pump System
PMA Number
P080012
Supplement Number
S068
Device Class
FDA Class 3
Product Code
LKK
Generic Name
Pump, infusion, implanted, programmable
Medical Specialty
Unknown
Advisory Committee
General Hospital
Decision
Approved
Decision Code
APPR
Decision Date
January 12, 2022
Date Received
November 5, 2020
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
22M-0090

Advisory Committee Statement

Approval for the Prometra® Programmable Infusion Pump System. The device is indicated for intrathecal infusion of drug therapy, including: Infumorph ® (preservative free morphine sulfate sterile solution), preservative-free sterile 0.9% saline solution (Sodium Chloride Injection, USP), and baclofen (baclofen injection, intrathecal, 500-2000 mcg/mL). For Infumorph, the pump system is indicated for use in patient populations of 22 years and older (adults). For baclofen, the pump system is indicated for use in patient populations of 12 years and older (pediatric adolescents and adults).

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LKK Pump, Infusion, Implanted, Programmable